Digestible: IBS Relief
By Digestible
Digestible: IBS Relief is a medical app for IBS patients that uses brain-gut retraining and CBT to reduce symptom triggers.
The App DNA
What makes this app unique?
The app removes the cognitive load of managing chronic gut symptoms by providing a guided, professional-grade protocol that replaces trial-and-error dietary restriction.
For Individuals with chronic IBS who have not found relief through traditional diet-based or symptom-management approaches.
What does it look like?
Key features
Guided audio content focused on brain-gut connection retraining.
Protocol designed to reduce food fear and expand diet through nervous system regulation.
On-demand digital tools for managing IBS flare-ups in the moment.
How much does it cost?
The $149/year price point positions Digestible: IBS Relief as a premium therapeutic service, requiring a high-intent user base to justify the annual commitment.
Velocity
Maintenance developmentUX improvementsperformanceShow more...
Digestible: IBS Relief is currently in a maintenance cycle, having shipped only one version in the observed window. With the latest update occurring 109 days ago, the development cadence is approximately one release every 3.6 months. The most recent update focused on minor UX improvements and educational content rather than significant new features. The current pace suggests a stable but slow development trajectory.
Who built it?
User Sentiment
What do users think recently?
Fresh user feedback skews thrilled. Users appreciate clean and calming interface design helps users focus on the brain-stomach connection without visual clutter and educational content provided by medical professionals helps users manage complex gut health data points effectively.
How are ratings & reviews evolving?
What users say, by theme
- Clean and calming interface design helps users focus on the brain-stomach connection without visual clutter
- Educational content provided by medical professionals helps users manage complex gut health data points effectively
2 of 2 recent reviews analyzed · limited sample
Read the full review analysisCompetition
Competitive landscape for Digestible: IBS Relief
How's the Medical market?
Digestible: IBS Relief occupies a specialized medical niche, currently ranking in the top 100 grossing category in multiple international markets. The app's focus on clinical protocols differentiates it from general-purpose health trackers, though its high annual price point creates a barrier to mass-market adoption.
The rivals identified
The Analyst's Read
Key takeaways for Digestible: IBS Relief
Where is it heading?
The digital GI health market is consolidating around evidence-based protocols, and Digestible: IBS Relief is well-positioned to capture users seeking alternatives to diet-only management. However, the app must address its high-friction pricing to avoid losing market share to more accessible, monthly-billed competitors.
- Medically-backed educational content drives high user satisfaction, which provides a strong foundation for long-term retention in the chronic health segment.
- The $149/year annual subscription model creates a high conversion friction that limits the app's ability to compete with lower-cost, monthly-billed health tools.
The SWOT
- Clinical methodology provides a defensible barrier against symptom-tracking rivals.
- Medically-backed educational content drives high user satisfaction.
- Localized content could capture users in regions with limited GI psychology access.
- B2B partnerships with gastroenterology clinics could provide a high-intent acquisition channel.
Next best moves
Introduce a monthly subscription tier because the $149/year price is a high barrier to entry → increase conversion rate
+ 1 more prioritized moveThe counter-intuitive read
The app's high price is not a weakness…
Read the full takeFeature gaps
B2B-gated access (available in Sword Health but missing here)
Since the last report: This report establishes the initial competitive baseline for Digestible: IBS Relief. No historical data exists to track changes in features, pricing, or sentiment.
Bottom line
Digestible: IBS Relief offers a distinct clinical value proposition, but the high annual price point restricts its funnel. Introducing a monthly tier would lower the barrier to entry, allowing the app to scale its user base while maintaining its premium positioning.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated